Bill Information > HB 2710
Search for another bill or initiative:
HB 2710 - 2019-20
Modifying the uses, disclosure, and requirement dates of prescription drug price transparency data.
See Bill History for complete details on the bill
Where is it in the process?
2020 REGULAR SESSION
First reading, referred to Health Care & Wellness. (View Original Bill)
Public hearing in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
Executive action taken in the House Committee on Health Care & Wellness at 1:30 PM. (Committee Materials)
HCW - Majority; do pass. (Majority Report)
Referred to Rules 2 Review.
Rules Committee relieved of further consideration. Placed on second reading.
Rules suspended. Placed on Third Reading.
Third reading, passed; yeas, 56; nays, 42; absent, 0; excused, 0. (View Roll Calls)
IN THE SENATE
First reading, referred to Health & Long Term Care.
Public hearing and executive session scheduled, but no action was taken in the Senate Committee on Health & Long Term Care at 8:00 AM. (Committee Materials)
By resolution, returned to House Rules Committee for third reading.
For a complete list of documents, go to Online Reports Text of a Legislative Document.